PolyPid Ltd. (NASDAQ:PYPD – Get Rating)’s stock price traded up 4.8% on Wednesday . The company traded as high as $0.39 and last traded at $0.37. 94,833 shares traded hands during trading, a decline of 67% from the average session volume of 288,958 shares. The stock had previously closed at $0.35.
PolyPid Trading Up 4.8 %
The business has a 50-day moving average price of $0.42 and a two-hundred day moving average price of $0.64. The stock has a market capitalization of $7.18 million, a P/E ratio of -0.22 and a beta of 1.25. The company has a current ratio of 2.75, a quick ratio of 2.75 and a debt-to-equity ratio of 0.59.
PolyPid (NASDAQ:PYPD – Get Rating) last released its earnings results on Wednesday, May 10th. The company reported ($0.28) earnings per share for the quarter. On average, analysts expect that PolyPid Ltd. will post -1.05 EPS for the current fiscal year.
Institutional Trading of PolyPid
PolyPid Company Profile
PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well as for the prevention of abdominal (soft tissue) SSIs.
- Get a free copy of the StockNews.com research report on PolyPid (PYPD)
- Toll Brothers Rises On Results, But The Roof Is In Place
- It’s Time To Try On VF Corporation’s 6% Yield
- PetCo Management Getting it Right? Earnings Beat Says Yes
- Axcelis Stock In Buy Range After Chart Breakout, Strong Guidance
- Kohl’s 10% Yield Comes Into High Fashion
Receive News & Ratings for PolyPid Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PolyPid and related companies with MarketBeat.com's FREE daily email newsletter.